At a glance
ClinicalIndex Comparison RecordN/ACompleted· 241 enrolled
Drug / intervention
Accolade® TMZF® Hip Stemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Accolade® TMZF® Study A Prospective, Post-market, Non-randomized, Multi-center Evaluation of the Accolade® TMZF® Hip Stem
In Brief
A clinical study evaluating Accolade® TMZF® Hip Stem for Arthroplasty, Replacement, Hip. Completed, enrolled 241 participants across 11 sites.
Detailed Summary
The purpose of this study is to evaluate clinical and radiographic outcome data in patients implanted with the Accolade® TMZF® femoral stem.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArthroplasty, Replacement, Hip
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2006
First PostedAug 2009
Primary CompletionMay 2011
Study CompletionMay 2014
TodayJul 2026
First PostedAug 12, 2009
Enrollment StartMar 1, 2006
Primary CompletionMay 1, 2011
Study CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 16.9 years ago
Interventions
Accolade® TMZF® Hip Stemdevice
Accolade® TMZF® Hip Stem